Debt-to-equity of Silo Pharma, Inc. from 30 Sep 2013 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Silo Pharma, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2013 to 30 Sep 2025.
  • Silo Pharma, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 39%, a 33% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Silo Pharma, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 39% +10% +33% 30 Sep 2025
Q2 2025 38% +10% +38% 30 Jun 2025
Q1 2025 37% +13% +53% 31 Mar 2025
Q4 2024 34% +13% +63% 31 Dec 2024
Q3 2024 29% +11% +65% 30 Sep 2024
Q2 2024 27% +12% +80% 30 Jun 2024
Q1 2024 24% +11% +84% 31 Mar 2024
Q4 2023 21% +8% +66% 31 Dec 2023
Q3 2023 18% +4% +32% 30 Sep 2023
Q2 2023 15% +1% +6.3% 30 Jun 2023
Q1 2023 13% -3% -18% 31 Mar 2023
Q4 2022 13% -6% -34% 31 Dec 2022
Q3 2022 13% -7% -33% 30 Sep 2022
Q2 2022 14% -10% -42% 30 Jun 2022
Q1 2022 16% 0% -2.3% 31 Mar 2022
Q4 2021 19% 31 Dec 2021
Q3 2021 20% 30 Sep 2021
Q2 2021 25% 30 Jun 2021
Q1 2021 17% 31 Mar 2021
Q4 2013 31% 31 Dec 2013
Q3 2013 107% 30 Sep 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.